Current Cancer Drug Targets
Country
United Arab Emirates
Middle East
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Drug Discovery
Q2
└
Pharmacology
Q2
└
Cancer Research
Q3
Publisher
SJR 2025
0.726
Q2
SJR Score
H-Index
109
Citations / Doc (2yr)
2.95
Total Docs. (latest)
204
Total Citations (3yr)
734
Publication type
Journals
ISSN
15680096, 18735576
Coverage
2001-2026
Journal Rank
#7,884
Subject Categories
Drug Discovery
Q2
Pharmacology
Q2
Cancer Research
Q3
Oncology
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 204 |
| Total Docs. (3 years) | 243 |
| Total Refs. | 17,206 |
| Total Citations (3 years) | 734 |
| Citable Docs. (3 years) | 238 |
| Citations / Doc. (2 years) | 2.95 |
| Ref. / Doc. | 84.34 |
| % Female | 44.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Current Cancer Drug Targets?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Current Cancer Drug Targets has an SJR of 0.726 and is ranked Q2.
What is the SJR and quartile of Current Cancer Drug Targets?
Current Cancer Drug Targets has an SJR (SCImago Journal Rank) of 0.726 and its best quartile is Q2.
What is the H-index of Current Cancer Drug Targets?
The H-index of Current Cancer Drug Targets is 109, meaning 109 of its articles have each been cited at least 109 times.
Is Current Cancer Drug Targets indexed in Scopus?
Yes. Current Cancer Drug Targets is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.